Emerging uses of circulating tumor DNA in advanced stage non-small cell lung cancer

Targeted therapies have dramatically changed the treatment paradigm for a select group of patients with non-small cell lung cancer (NSCLC) whose tumors harbor targetable genetic aberrations. Patients with such genetic changes enjoy excellent responses to tyrosine kinase inhibitors (TKIs), but resist...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Transl Med
Main Authors: Marmarelis, Melina, Thompson, Jeffrey C., Aggarwal, Charu, Evans, Tracey L., Carpenter, Erica, Cohen, Roger B., Langer, Corey J., Bauml, Joshua
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2017
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5635259/
https://ncbi.nlm.nih.gov/pubmed/29057240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.07.29
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados